REDWOOD CITY, Calif.--(BUSINESS WIRE)--Gynesonics, Inc., developer of the VizAblate™ system, a minimally invasive device to treat uterine fibroid tumors, announced today that Karen D. Talmadge, PhD, Executive Vice President, Co-Founder and Chief Science Officer of Kyphon Inc., has joined its Board of Directors.
